CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
NCT01781468
Clinical Trial Information
Trial Number: NCT01781468 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
- CNS Neoplasm (Primary Tumor) - Oligodendroglial Tumors
Trial Title:
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Study ID:
A221101
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01781468-D2 | Dataset NCT01781468-D2-Dataset.csv (final_cytox) is one of 2 datasets associated with PubMed ID 34882169. This dataset contains data presented in Table 4. |
| NCT01781468-D1 | Dataset NCT01781468-D1-Dataset.csv (final_analysis) is one of 2 datasets associated with PubMed ID 34882169. This dataset contains data presented in the Consort Diagram, Table 1, Table 2, Table 3, eTable 1, eTable 2, eTable 3, eTable 4, and eTable 5. |
NCT00004259
Clinical Trial Information
Trial Number: NCT00004259 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
Trial Title:
A Phase III Randomized Study (Phase I Closed) of Radiation Therapy and Temozolomide Versus Radiation Therapy and Nitrosourea for Anaplastic Astrocytoma And Mixed Anaplastic Oligoastrocytoma (Astrocytoma Dominant)
Study ID:
RTOG-98-13
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®